Dr. Thomas Page has over 35 years of Life Sciences experience in biotechnology and CDMO companies supporting product development, operations, engineering, process development, and business development. His product expertise includes blood-based products, vaccines, recombinant proteins, mAbs, and advanced therapy medicinal products. Dr. Page has led the design, construction, validation, and operations for over $1 Billion in assets in both the public and private sector over the course of his career. He has numerous patents and publications and is passionate about enabling faster, better, cheaper responses to pandemics and emerging threats and supporting the next generation of bioprocess technologies, biotechnologists and biotechnology hubs. Dr. Page currently serves as Acting CTO for Komo Biosciences, as a strategic advisor to a number of other companies and is on the ISPE south central regional board.